Why the Obesity Drug Revolution Is a Work in Progress
5 days ago · A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially …
FDA declares the shortage of obesity drug ... - Health News Florida
Dec 28, 2024 · The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. And like Ozempic and Wegovy, …
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most …
Merck moves into obesity with deal for Hansoh’s GLP-1 pill
Dec 18, 2024 · Dive Brief: Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a …
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s …
The Coming Wave of New Obesity-Treatment Drugs - Bloomberg.com
Dec 13, 2024 · Until now, just two companies have dominated the obesity-treatment market: Denmark’s Novo Nordisk A/S and its US rival Eli Lilly & Co. Ozempic and Wegovy, made by …
New Obesity Drug MariTide Helps Patients Lose Up to 20% of …
Nov 26, 2024 · The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The …
Why weight-loss drugs may be no obesity silver bullet - BBC News
Oct 15, 2024 · Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given as regular injections, the treatments – Wegovy …
FDA approves Zepbound, a new obesity drug that will take on …
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
F.D.A. Approves New Obesity Drug That Will Compete With …
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.